February 2021

Treatment and Outcomes Data Are Evolving for Patients With COVID-19 and Cancer

March 02, 2021

Directions in Pharmacy

The CDC recommends that patients with cancer and COVID-19 have a conversation with their health care provider or care team to discuss the individual level of risk based on the patient’s current condition, treatment, and the level of transmission within their community.

Biomarkers Predict Response to Treatment in Cervical and Endometrial Cancers

February 24, 2021

Directions in Pharmacy

In a live virtual symposium presented at the 2020 ASHP Midyear Clinical Meeting and Exhibition, Allison Baxley, PharmD, BCOP, and Laura Alwan, PharmD, BCOP, engaged pharmacists in learning about the role of biomarkers in cervical and endometrial cancers.

Clearing the Confusion about Dosing Immune Checkpoint Inhibitors

February 23, 2021

Directions in Pharmacy

Two expert speakers at the 2020 ASHP Midyear Clinical Meeting and Exhibition presented Immune Checkpoint Inhibitors: Resolving Dosing Confusion to Better Care for Patients With Cancer, a virtual symposium.

The Impact of COVID-19 on Oncology Pharmacy and Patient Care, Part 1

February 17, 2021

Directions in Pharmacy

Medication reconciliation is a critical component of the oncology pharmacistʼs duties that has been performed safely over the phone with the patient, caregiver, and pharmacy with the assistance of electronic health records.